Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,204 | 10,114 | 21,631 | 14,758 | 12,497 |
| Marketable Securities | 15,434 | 15,024 | 0 | N/A | N/A |
| Receivables | 1,159 | 4,695 | 4,141 | 4,263 | 3,562 |
| Inventories | 2,627 | 3,636 | 2,586 | 2,533 | 2,377 |
| Other current assets | 2,195 | 0 | 0 | 0 | 0 |
| TOTAL | $35,903 | $34,137 | $28,856 | $22,651 | $19,539 |
| Non-Current Assets | |||||
| PPE Net | 927 | 1,481 | 519 | 692 | 822 |
| Intangibles | 0 | 0 | 0 | 18,770 | 23,815 |
| Other Non-Current Assets | 39 | 464 | 484 | 1,645 | 1,446 |
| TOTAL | $966 | $1,945 | $1,003 | $21,107 | $26,083 |
| Total Assets | $36,869 | $36,083 | $29,859 | $43,757 | $45,623 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 145 | 168 |
| Accounts payable and accrued liabilities | 1,436 | 3,526 | 5,394 | 3,662 | 2,086 |
| Accrued Expenses | 2,217 | 3,017 | 4,491 | 4,588 | 4,981 |
| TOTAL | $3,746 | $6,637 | $26,859 | $8,395 | $7,234 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | N/A | 48,200 | 43,201 |
| Deferred Revenues | 94 | 94 | 16,974 | N/A | N/A |
| Other Non-Current Liabilities | 1,174 | 8,169 | 22,759 | 4,058 | 0 |
| TOTAL | $1,207 | $8,215 | $22,913 | $52,587 | $43,507 |
| Total Liabilities | $4,953 | $14,852 | $49,772 | $60,982 | $50,741 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,938 | 10,916 | 10,490 | 8,201 | 6,807 |
| Common Shares | 109 | 874 | 844 | 658 | 540 |
| Retained earnings | -248,366 | -258,283 | -278,810 | -256,979 | -235,110 |
| Other shareholders' equity | 708 | 580 | 451 | 518 | 764 |
| TOTAL | $31,916 | $21,231 | $-19,914 | $-17,224 | $-5,118 |
| Total Liabilities And Equity | $36,869 | $36,083 | $29,859 | $43,757 | $45,623 |